Filing Details

Accession Number:
0001179110-17-012300
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-14 17:45:20
Reporting Period:
2017-09-12
Accepted Time:
2017-09-14 17:45:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203301 W Myron Wentz 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-12 26,207 $57.91 12,272,013 No 4 S Indirect Shares owned of record by Gull Global Limited
Common Stock Disposition 2017-09-13 18,861 $57.39 12,253,152 No 4 S Indirect Shares owned of record by Gull Global Limited
Common Stock Disposition 2017-09-14 34,226 $57.51 12,218,926 No 4 S Indirect Shares owned of record by Gull Global Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Shares owned of record by Gull Global Limited
No 4 S Indirect Shares owned of record by Gull Global Limited
No 4 S Indirect Shares owned of record by Gull Global Limited
Footnotes
  1. The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
  2. Weighted average price. Price range in multiple transactions was $57.80 to $58.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
  3. Weighted average price. Price range in multiple transactions was $57.20 to $58.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
  4. Weighted average price. Price range in multiple transactions was $57.40 to $557.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.